Amiloride

Overview

Amiloride (MK-870) is an inhibitor of both epithelial sodium channel ( ENaC ) and urokinase-type plasminogen activator receptor ( uTPA ). Amiloride is a blocker of polycystin-2 (PC2; TRPP2 ) channel.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pain | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Sodium Channel | Products > Signaling Pathways > TRP Channel | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-B0285
• CAS No.: 2609-46-3
• Molecular Formula: C6H8ClN7O
• Molecular Weight: 229.63
• Purity: 99.96%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (10.89 mM); Clear solution
• Availability: In-stock

Source

Original product source